ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 28 filers reported holding ELEVATION ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,799 | -60.6% | 37,427 | -9.6% | 0.00% | – |
| Q2 2023 | $62,936 | +1.1% | 41,405 | +26.4% | 0.00% | – |
| Q1 2023 | $62,227 | +74.5% | 32,751 | -12.8% | 0.00% | – |
| Q4 2022 | $35,664 | -15.1% | 37,542 | +1.8% | 0.00% | – |
| Q3 2022 | $42,000 | -19.2% | 36,866 | -2.2% | 0.00% | – |
| Q2 2022 | $52,000 | -45.8% | 37,711 | -1.3% | 0.00% | – |
| Q1 2022 | $96,000 | -34.2% | 38,218 | +57.4% | 0.00% | – |
| Q4 2021 | $146,000 | -21.5% | 24,282 | +1.9% | 0.00% | – |
| Q3 2021 | $186,000 | – | 23,837 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
| Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
| venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
| TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
| Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
| DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
| Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
| CAXTON CORP | 21,813 | $14,453 | 0.06% |
| BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |